Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Search results for:
ALPRAZolam
ALPRAZolam
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
ALPRAZolam ER
TABLET, EXTENDED RELEASE, ORAL
1 mg
Alprazolam
TABLET, ORAL
0.25 mg
Xanax
TABLET, ORAL
0.25 mg
Alprazolam
TABLET, ORAL
0.5 mg
Alprazolam
TABLET, ORAL
1 mg
VIEW MORE
Benzodiazepines
CLASS
282408
Additional Information:
Drug Name
Common Side Effects
alprazolam
drowsiness, light-headedness
dry mouth
changes in appetite (increased or decreased)
Last updated:
Aug. 22, 2022
Black Box Warning:
Risks From Concomitant Use in Opioids
Do Not Crush:
Extended-release Tablet
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Rhazdrugs:
ALPRAZolam